|
Glycosylated Hemoglobin (HbA1c) Quantitative Test Cassette (Quantum Dot Fluorescence Immunochromatography)
HbA1c measurement in professional settings depends on method, sample handling, reader compatibility, and documentation. The supplied listing identifies a Guoke Medical cassette for whole-blood HbA1c quantification.
Blood glucose testing in professional laboratories can involve different assay formats. This cassette is listed in Guoke Medical’s Testing for Blood Glucose portfolio for professional diagnostic or laboratory use.
The stated method is fluorescent lateral flow immunochromatography, using a double antibody sandwich format for quantitative detection of HbA1c in human whole blood. Those are the central verified claims in the source material.
The product code is GKPD066, packed as 25 tests per box. The specification table lists biomarker as whole blood, which buyers should confirm against their intended sample type and laboratory protocol.
The input does not identify a compatible fluorescence reader or analyzer, calibration method, controls, or result units. A laboratory should verify those points before assuming the cassette fits existing equipment.
Procurement terms are also open. Availability, pack size or configuration, compatible options, documentation, MOQ, lead time, shipping, and quotation require direct confirmation from Scientific China.
For professional diagnostic use, buyers should request instructions for use, labeling, storage conditions, shelf life, lot information, and applicable regulatory or quality documents for their market.
Why it matters:
The purchase decision hinges on confirmed method, reader compatibility, sample type, and documentation. Those checks determine whether the cassette can enter a routine laboratory workflow.
View Product →
|
ScientificChina — tracking China’s science, technology, and industrial systems through the lens of real-world products.
Follow ScientificChina for deeper insight into the infrastructure behind global innovation.
Visit ScientificChina.
ScientificChina is an independent commercial platform and is not affiliated with or endorsed by any Chinese government agency or public institution.
|
|